Loratadine and Pseudoephedrine Sulfate · LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 · Tablet, Film Coated, Extended Release · Oral · Major Pharmaceuticals
NDC 00904-5833-15 · 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →
12 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.5656 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Heb | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Strategic Sourcing Services LLC | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Amerisource Bergen | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Foundation Consumer Brands | LORATADINE 5 mg/1; PSEUDOEPHEDRINE SULFATE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Meijer Distribution, Inc. | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | LORATADINE 5 mg/1; PSEUDOEPHEDRINE SULFATE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Publix Super Markets Inc | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Safeway Inc. | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strategic Sourcing Services | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| The Kroger Company | LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Loratadine and Pseudoephedrine Sulfate — NDC 00904-5833-15," retrieved September 3, 2026, https://drugdashboards.com/drug/00904583315.
Free to cite with attribution — see how the data is put together.